SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Akero Therapeutics, Inc. AKRO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Akero Therapeutics, Inc. (AKRO) has 12 identified peers for comparison in the Healthcare sector. Peers include BCEL, BDTX, ICPT, INZY, MDGL, PASG and others.

AKRO has a market capitalization of $4.5B, compared to an average peer market cap of $4.84B.

Peers & Similar Companies — AKRO

$0.09 -1.32% $3.57M

Black Diamond Therapeutics, Inc.

$2.66 -2.21% $152.39M

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

Inozyme Pharma, Inc.

$4.00 +0.25% $258.25M

Madrigal Pharmaceuticals, Inc.

$524.99 -0.13% $12.04B

Passage Bio, Inc.

$10.86 +0.46% $34.84M

Protagonist Therapeutics, Inc.

$104.72 +7.33% $6.68B

Reata Pharmaceuticals, Inc.

$172.36 +0.02% $6.57B

Avidity Biosciences, Inc.

$14.02 +5.41% $217.52M

Revolution Medicines, Inc.

$147.01 +7.86% $29.13B

Stoke Therapeutics, Inc.

$35.86 +2.31% $2.12B

TCR2 Therapeutics Inc.

$1.48 0.00% $58.11M

People Also View

Revolution Medicines, Inc.

Madrigal Pharmaceuticals, Inc.

Protagonist Therapeutics, Inc.

Reata Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

Viking Therapeutics, Inc.

Stoke Therapeutics, Inc.

Intercept Pharmaceuticals, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message